References
- SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
- EsnaolaNFGebregziabherMFinneyCFordMEUnderuse of surgical resection in black patients with nonmetastatic colorectal cancer: location, location, locationAnn Surg2009250454955719730243
- GillSLoprinziCLSargentDJPooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?J Clin Oncol200422101797180615067028
- SargentDSobreroAGrotheyAEvidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trialsJ Clin Oncol200927687287719124803
- SchragDRifas-ShimanSSaltzLBachPBBeggCBAdjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancerJ Clin Oncol200220193999400512351597
- SchippingerWSamoniggHSchaberl-MoserRAustrian Breast and Colorectal Cancer Study GroupA prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancerBr J Cancer20079781021102717895886
- Quasar Collaborative GroupGrayRBarnwellJAdjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised studyLancet200737096042020202918083404
- MamounasEWieandSWolmarkNComparative efficacy of adjuvant chemotherapy in patients with Dukes’ B versus Dukes’ C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)J Clin Oncol19991751349135510334518
- FigueredoACharetteMLMarounJBrouwersMCZurawLAdjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site groupJ Clin Oncol200422163395340715199087
- WilkinsonNWYothersGLopaSCostantinoJPPetrelliNJWolmarkNLong-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trialsAnn Surg Oncol201017495996620082144
- BensonAB3rdSchragDSomerfieldMRAmerican Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancerJ Clin Oncol200422163408341915199089
- QuahHMChouJFGonenMIdentification of patients with high-risk stage II colon cancer for adjuvant therapyDis Colon Rectum200851550350718322753
- ChangGJRodriguez-BigasMASkibberJMMoyerVALymph node evaluation and survival after curative resection of colon cancer: systematic reviewJ Natl Cancer Inst200799643344117374833
- ChenHSSheen-ChenSMObstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trendsSurgery2000127437037610776426
- SwansonRSComptonCCStewartAKBlandKIThe prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examinedAnn Surg Oncol2003101657112513963
- ChenSLBilchikAJMore extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based studyAnn Surg2006244460261016998369
- Le VoyerTESigurdsonERHanlonALColon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089J Clin Oncol200321152912291912885809
- HashiguchiYHaseKUenoHPrognostic significance of the number of lymph nodes examined in colon cancer surgery: clinical application beyond simple measurementAnn Surg2010251587288120395864
- MooreJHymanNCallasPLittenbergBStaging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survivalSurgery2010147335836519962166
- About the SEER Program – SEER – Overview of the SEER Program2010 Available from: https://seer.cancer.gov/about/overview.htmlAccessed July 10, 2018
- WarrenJLKlabundeCNSchragDBachPBRileyGFOverview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly populationMed Care200240Suppl 8IV-318
- SEER ICD-O-3 Coding Materials2009 Available from: https://seer.cancer.gov/icd-o-3/Accessed July 10, 2018
- SchragDPanageasKSRiedelESurgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resectionJ Surg Oncol20038326878 discussion 78–6912772198
- EtzioniDACannomRRMadoffRDAultGTBeartRWJrColorectal procedures: what proportion is performed by American board of colon and rectal surgery-certified surgeons?Dis Colon Rectum201053571372020389204
- ObeidatNAPradelFGZuckermanIHDeLisleSMullinsCDOutcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancerAm J Geriatr Pharmacother20097634335420129255
- WarrenJLHarlanLCFaheyAUtility of the SEER-Medicare data to identify chemotherapy useMed Care2002408 SupplIV-5561
- GoodwinJSNguyen-OghalaiTUKuoYFOttenbacherKJEpidemiology of Medicare abuse: the example of power wheelchairsJ Am Geriatr Soc200755222122617302658
- DuXLFangSCokerALRacial disparity and socioeconomic status in association with survival in older men with local/regional stage prostate carcinoma: findings from a large community-based cohortCancer200610661276128516475208
- EarleCCNattingerABPotoskyALIdentifying cancer relapse using SEER-Medicare dataMed Care2002408 SupplIV-7581
- LuncefordJKStratification and weighting via the propensity score in estimation of causal treatment effects: a comparative studyStat Med20173614232028573784
- EsnaolaNFFordNERacial differences and disparities in cancer care and outcomes: where’s the rub?Surg Oncol Clin N Am2012721341743722583991